Skip to Content
MilliporeSigma
  • Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.

Critical roles for nitric oxide and ERK in the completion of prosurvival autophagy in 4OHTAM-treated estrogen receptor-positive breast cancer cells.

Cancer letters (2014-07-30)
Lei Duan, Brian Danzer, Victor V Levenson, Carl G Maki
ABSTRACT

Autophagy is a mechanism of tamoxifen (TAM) resistance in ER-positive (ER+) breast cancer cells. In this study, we showed in ER+ MCF7 cells that 4-hydroxytamoxifen (4OHTAM) induced cellular nitric oxide (NO) that negatively regulates cellular superoxide (O2-) and cytotoxicity. 4OHTAM stimulated LC3 lipidation and formation of monodansylcadaverine (MDC)-labeled autophagic vesicles dependent on O2-. Depletion of NO increased O2- and LC3 lipidation, yet reduced formation of MDC-labeled autophagic vesicles. Instead, NO-depleted cells formed remarkably large vacuoles with rims decorated by LC3. The vacuoles were not labeled by MDC or the acidic lysosome-specific fluorescence dye acridine orange (AO). The vacuoles were increased by the late stage autophagy inhibitor chloroquine, which also increased LC3 lipidation. These results suggest NO is required for proper autophagic vesicle formation or maturation at a step after LC3 lipidation. In addition, 4OHTAM induced O2--dependent activation of ERK, inhibition of which destabilized lysosomes/autolysosomes upon 4OHTAM treatment and together with depletion of NO led to necrotic cell death. These results suggest an essential role for endogenous NO and ERK activation in the completion of pro-survival autophagy.

MATERIALS
Product Number
Brand
Product Description

Tamoxifen citrate for performance test, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Propidium iodide, ≥94% (HPLC)
Sigma-Aldrich
Tamoxifen citrate salt, ≥99%
Sigma-Aldrich
Propidium iodide, ≥94.0% (HPLC)
Sigma-Aldrich
Acridine Orange hydrochloride solution, 10 mg/mL in H2O, ≥95.0% (HPLC)
Sigma-Aldrich
(Z)-4-Hydroxytamoxifen, ≥98% Z isomer
Sigma-Aldrich
4-Hydroxytamoxifen, ≥70% Z isomer (remainder primarily E-isomer)
Tamoxifen citrate, European Pharmacopoeia (EP) Reference Standard
Supelco
4-Hydroxytamoxifen, analytical standard, (E) and (Z) isomers (50:50)
Supelco
4-Hydroxytamoxifen, (E) and (Z) isomers (50:50), analytical standard
Supelco
Tamoxifen, analytical standard
Sigma-Aldrich
Propidium iodide solution
Sigma-Aldrich
Tamoxifen, ≥99%